These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29621743)

  • 1. B cell depleting therapy for multiple sclerosis overlapping with neuromyelitis optica spectrum disorder.
    Lu T; Shu Y; Dai Y; Liu X; Chang Y; Huang Q; Kermode AG; Qiu W
    Mult Scler Relat Disord; 2018 May; 22():83-85. PubMed ID: 29621743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral CD19
    Ellrichmann G; Bolz J; Peschke M; Duscha A; Hellwig K; Lee DH; Linker RA; Gold R; Haghikia A
    J Neurol; 2019 Jan; 266(1):57-67. PubMed ID: 30377816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromyelitis optica spectrum disorder mimicking multiple sclerosis.
    van Rooij LC; Wattjes MP; de Jong BA; van Oosten BW
    Mult Scler Relat Disord; 2017 Oct; 17():54-56. PubMed ID: 29055475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of seropositive Neuromyelitis Optica in a paediatric patient with co-existing acute nephrotic syndrome.
    Volkman T; Hemingway C
    Mult Scler Relat Disord; 2017 Nov; 18():103-105. PubMed ID: 29141789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up.
    Evangelopoulos ME; Andreadou E; Koutsis G; Koutoulidis V; Anagnostouli M; Katsika P; Evangelopoulos DS; Evdokimidis I; Kilidireas C
    J Neurol Sci; 2017 Jan; 372():92-96. PubMed ID: 28017256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian family.
    Gelibter S; Mazzi B; Tassara M; Colombo B; Guerrieri S; Giordano A; Preziosa P; Comola M; Esposito F; Martinelli V; Rocca MA; Comi G; Leocani L; Martinelli-Boneschi F
    Mult Scler Relat Disord; 2018 Oct; 25():73-76. PubMed ID: 30053751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Movement disorders in multiple sclerosis and neuromyelitis optica: A clinical marker of neurological disability.
    Candeias da Silva C; Bichuetti DB; Azevedo Silva SMC; Ferraz HB; Oliveira EML; Borges V
    Parkinsonism Relat Disord; 2018 Jun; 51():73-78. PubMed ID: 29530725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorders by multiparametric quantitative MRI using convolutional neural network.
    Hagiwara A; Otsuka Y; Andica C; Kato S; Yokoyama K; Hori M; Fujita S; Kamagata K; Hattori N; Aoki S
    J Clin Neurosci; 2021 May; 87():55-58. PubMed ID: 33863534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Demyelinating Disorders in Pregnancy.
    Kaplan TB
    Neurol Clin; 2019 Feb; 37(1):17-30. PubMed ID: 30470273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic demyelination causing panhypopituitarism.
    Dixon-Douglas J; Burgess J; Dreyer M
    Intern Med J; 2018 May; 48(5):580-582. PubMed ID: 29722193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal cord atrophy in neuromyelitis optica spectrum disorders.
    Wang Y; Wang Y; Tan S; Lu Z
    Mult Scler Relat Disord; 2016 Jul; 8():9-10. PubMed ID: 27456868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seropositive neuromyelitis optica: a pediatric case report and 6-year follow-up.
    Maraş H; Kara B; Anık Y
    Pediatr Neurol; 2013 Sep; 49(3):198-202. PubMed ID: 23831249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica).
    Carroll WM; Saida T; Kim HJ; Kira J; Kermode AG; Tsai CP; Fujihara K; Kusunoki S; Tanaka M; Kim KK; Bates D;
    Mult Scler; 2013 Sep; 19(10):1371-80. PubMed ID: 23325588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal Cord Imaging in Multiple Sclerosis and Related Disorders.
    Jasperse B
    Neuroimaging Clin N Am; 2024 Aug; 34(3):385-398. PubMed ID: 38942523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of neuromyelitis optica.
    Wingerchuk DM; Lennon VA; Lucchinetti CF; Pittock SJ; Weinshenker BG
    Lancet Neurol; 2007 Sep; 6(9):805-15. PubMed ID: 17706564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging.
    Pekcevik Y; Mitchell CH; Mealy MA; Orman G; Lee IH; Newsome SD; Thompson CB; Pardo CA; Calabresi PA; Levy M; Izbudak I
    Mult Scler; 2016 Mar; 22(3):302-11. PubMed ID: 26209588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging in neuromyelitis optica.
    Tackley G; Kuker W; Palace J
    Mult Scler; 2014 Aug; 20(9):1153-64. PubMed ID: 24829291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromyelitis Optica Spectrum Disorder and Other Non-Multiple Sclerosis Central Nervous System Inflammatory Diseases.
    Flanagan EP
    Continuum (Minneap Minn); 2019 Jun; 25(3):815-844. PubMed ID: 31162318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.
    Fan S; Xu Y; Ren H; Guan H; Feng F; Gao X; Ding D; Fang F; Shan G; Guan T; Zhang Y; Dai Y; Yao M; Peng B; Zhu Y; Cui L
    Mult Scler Relat Disord; 2018 Feb; 20():144-152. PubMed ID: 29414288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, immunopathogenesis and management of pediatric central nervous system inflammatory demyelinating conditions.
    Pohl D
    Curr Opin Neurol; 2008 Jun; 21(3):366-72. PubMed ID: 18451724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.